Headlands Technologies LLC Boosts Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Headlands Technologies LLC increased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 145.3% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,484 shares of the company’s stock after acquiring an additional 2,656 shares during the quarter. Headlands Technologies LLC’s holdings in Acadia Healthcare were worth $355,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in ACHC. Sei Investments Co. boosted its holdings in shares of Acadia Healthcare by 1.2% in the 1st quarter. Sei Investments Co. now owns 290,050 shares of the company’s stock valued at $22,977,000 after buying an additional 3,523 shares in the last quarter. Texas Permanent School Fund Corp increased its holdings in shares of Acadia Healthcare by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 80,706 shares of the company’s stock valued at $6,394,000 after purchasing an additional 1,045 shares in the last quarter. Quent Capital LLC increased its holdings in shares of Acadia Healthcare by 8.1% during the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock valued at $300,000 after purchasing an additional 284 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in shares of Acadia Healthcare by 77.1% during the 1st quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company’s stock valued at $1,700,000 after purchasing an additional 9,342 shares in the last quarter. Finally, Peterson Wealth Services purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $2,739,000.

Acadia Healthcare Trading Up 0.7 %

Shares of ACHC stock traded up $0.45 on Wednesday, hitting $68.93. 34,202 shares of the stock traded hands, compared to its average volume of 721,126. The firm’s 50-day moving average price is $67.38 and its two-hundred day moving average price is $74.94. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. The stock has a market capitalization of $6.40 billion, a PE ratio of -489.11, a PEG ratio of 1.95 and a beta of 1.31. Acadia Healthcare Company, Inc. has a twelve month low of $62.04 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The firm had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. During the same quarter in the previous year, the company posted $0.75 EPS. The company’s revenue was up 9.1% compared to the same quarter last year. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.52 EPS for the current year.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a report on Thursday, April 25th. Mizuho cut their price target on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating for the company in a report on Friday, May 3rd. Bank of America cut their price target on shares of Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, May 21st. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, July 9th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $87.56.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.